Cardiovascular Drugs and Therapy

, Volume 16, Issue 6, pp 521–526 | Cite as

In Vitro Ultrasound Augmented Clot Dissolution—What is the Optimal Timing of Ultrasound Application?

  • Gil Zvi Shlamovitz
  • Zaza Iakobishvili
  • Israel Matz
  • Gregori Golovchiner
  • Eli Lev
  • Robert J. Siegel
  • Yochai Birnbaum


The mechanism of ultrasound augmentation of pharmacological thrombolysis is yet unknown. The goal of this study is to find the best timing regimen for in-vitro ultrasound augmented clot dissolution by streptokinase, heparin and their combination. Blood clots from 4 donors were cut into 200–400 mg sections and randomized to no treatment with ultrasound; pre-treatment with ultrasound (before immersion); early treatment with ultrasound; or late treatment with ultrasound. Clots were placed in tubes containing either saline; heparin; streptokinase or streptokinase +heparin. All groups showed significant weight reduction (p < 0.001). Using the one way ANOVA test, we showed that ultrasound application resulted in a significantly higher rate of clots dissolution (p < 0.05) than without ultrasound in all of the solutions tested. We found no statistically significant difference between the three ultrasound regimens tested. In conclusion, in our in-vitro model, no single ultrasound timing schedule was found to provide better clot dissolution than the other schedules. This finding may suggest an additive effect between the ultrasound and the different solutions rather than a synergistic effect.

ultrasound thrombolysis in-vitro streptokinase heparin clot disruption 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nilsson AM, Odselius R, Roijer A, Olsson SB. Pro-and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis. Ultrasound Med Biol 1995;21:833–840.Google Scholar
  2. 2.
    Tachibana K, Tachibana S. Albumin microbubble echocontrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation 1995;92:1148–1150.Google Scholar
  3. 3.
    Tachibana K, Tachibana S. Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis. J Ultrasound Med 1997;16:529–535.Google Scholar
  4. 4.
    Francis CW, Blinc A, Lee S, Cox C. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995;21:419–424.Google Scholar
  5. 5.
    Harpaz D, Chen X, Francis CW, Meltzer RS. Ultrasound accelerates urokinase-induced thrombolysis and reperfusion. Am Heart J 1994;127:1211–1219.Google Scholar
  6. 6.
    Olsson SB, Johansson B, Nilsson AM, Olsson C, Roijer A. Enhancement of thrombolysis by ultrasound. Ultrasound Med Biol 1994;20:375–382.Google Scholar
  7. 7.
    Kimura M, Iijima S, Kobayashi K, Furuhata H. Evaluation of the thrombolytic effect of tissue-type plasminogen activator with ultrasonic irradiation: In vitro experiment involving assay of the fibrin degradation products from the clot. Biol Pharm Bull 1994;17:126–130.Google Scholar
  8. 8.
    Sehgal CM, Leveen RF, Shlansky-Goldberg RD. Ultrasound-assisted thrombolysis. Invest Radiol 1993;28:939–943.Google Scholar
  9. 9.
    Francis CW, Onundarson PT, Carstensen EL, et al. Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest 1992;90:2063–2068.Google Scholar
  10. 10.
    Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. Enhancement of fibrinolysis with 40-kHz ultrasound. Circulation 1998;98:1030–1035.Google Scholar
  11. 11.
    Blinc A, Francis CW, Trudnowski JL, Carstensen EL. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993;81:2636–2643.Google Scholar
  12. 12.
    Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM. Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis. Circulation 1992;86:1257–1264.Google Scholar
  13. 13.
    Hong AS, Chae JS, Dubin SB, Lee S, Fishbein MC, Siegel RJ. Ultrasonic clot disruption: An in vitro study. Am Heart J 1990;120:418–422.Google Scholar
  14. 14.
    Luo H, Steffen W, Cercek B, Arunasalam S, Maurer G, Siegel RJ. Enhancement of thrombolysis by external ultrasound. Am Heart J 1993;125:1564–1569.Google Scholar
  15. 15.
    Atar S, Luo H, Birnbaum Y, Nagai T, Siegel RJ. Augmentation of in-vitro clot dissolution by low frequency highintensity ultrasound combined with antiplatelet and antithrombotic drugs. J Thromb Thrombolysis 2001;11:223–228.Google Scholar
  16. 16.
    Wyshelesky A, Iakobishvili Z, Matz I, et al. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study. Thromb Res 2001;103:337–344.Google Scholar
  17. 17.
    Birnbaum Y, Atar S, Luo H, Nagai T, Siegel RJ. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution. Thromb Res 1999;96:451–458.Google Scholar
  18. 18.
    Riggs PN, Francis CW, Bartos SR, Penney DP. Ultrasound enhancement of rabbit femoral artery thrombolysis. Cardiovasc Surg 1997;5:201–207.Google Scholar
  19. 19.
    Luo H, Birnbaum Y, Fishbein MC, et al. Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound. Thromb Res 1998;89:171–177.Google Scholar
  20. 20.
    Luo H, Nishioka T, Fishbein MC,et al. Transcutaneous ultrasound augments lysis of arterial thrombi in vivo. Circulation 1996;94:775–778.Google Scholar
  21. 21.
    Siegel RJ, Atar S, Fishbein MC, et al. Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography 2001;18:247–257.Google Scholar
  22. 22.
    Birnbaum Y, Luo H, Atar S, et al. Noninvasive transthoracic low frequency ultrasound augments thrombolysis in a canine model of acute myocardial infarction-evaluation of the extent of st-segment resolution. J Thromb Thrombolysis 2001;11:229–234.Google Scholar
  23. 23.
    Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med Biol 2000;26:1153–1160.Google Scholar
  24. 24.
    Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. Binding of tissue-plasminogen activator to fibrin: Effect of ultrasound. Blood 1998;91:2019–2025.Google Scholar
  25. 25.
    Francis CW. Ultrasound-enhanced thrombolysis. Echocardiography 2001;18:239–246.Google Scholar
  26. 26.
    Birnbaum Y, Iakobishvili Z, Porter A, et al. Microparticlecontaining oncotic solutions augment in vitro clot disruption by ultrasound. Thromb Res 2000;98:549–557.Google Scholar
  27. 27.
    Nishioka T, Luo H, Fishbein MC, et al. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: An in vitro and in vivo study. J Am Coll Cardiol 1997;30:561–568.Google Scholar
  28. 28.
    Adler Y, Attar D, Vaturi M, et al. The effects of streptokinase and hydroxyethyl starch on-in vitro clot disruption by ultrasound. Cardiovascular Drugs and Therapy 2001;15:119–123.Google Scholar
  29. 29.
    Birnbaum Y, Luo H, Nagai T, et al. Noninvasive in vivo clot dissolution without a thrombolytic drug: Recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation 1998;97:130–134.Google Scholar
  30. 30.
    Shaw GJ, Hahn N, Wagner KR, Holland C. Ultrasoundassisted thrombolysis in an in vitro clot model. Acad Emerg Med 2001;8:542.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Gil Zvi Shlamovitz
    • 1
  • Zaza Iakobishvili
    • 1
  • Israel Matz
    • 1
  • Gregori Golovchiner
    • 1
  • Eli Lev
    • 1
  • Robert J. Siegel
    • 2
  • Yochai Birnbaum
    • 1
  1. 1.The laboratory of Cardiovascular Biology, Felsenstein Research Institute and the Department of CardiologyRabin Medical CenterPetah-TiqvaIsrael
  2. 2.The Division of CardiologyCedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations